Dose-response association of early-life antibiotic exposure and subsequent overweight or obesity in children: A meta-analysis of prospective studies
- PMID: 34328260
- DOI: 10.1111/obr.13321
Dose-response association of early-life antibiotic exposure and subsequent overweight or obesity in children: A meta-analysis of prospective studies
Abstract
The objective of this study is to investigate the dose-response relationship between antibiotic exposure in early life and the risk of subsequent overweight or obesity. Electronic databases were searched from inception to December 2020. Prospective studies that reported the odds ratios (ORs) of childhood overweight or obesity for three or more quantitative categories of antibiotic exposure were identified. A random-effect model was used to pool the ORs and 95% confidence intervals (CIs). Generalized least squares and restricted cubic splines were used to explore the dose-response association. A total of 12 sets of results from 10 articles involving 427,453 participants were included in this meta-analysis. The pooled OR for increased risk of overweight or obesity was 1.30 in high-level antibiotic exposure (95% CI: 1.20 to 1.41) and 1.06 in low-level antibiotic exposure (95% CI: 1.02 to 1.10), as compared with children who never exposed to antibiotics. There was a logarithmic-curve relationship between early-life antibiotic exposure and the risk of subsequent overweight or obesity. The OR was 1.08 (95% CI: 1.06 to 1.11) for one prescription, 1.16 (95% CI 1.11 to 1.21) for two prescriptions, 1.24 (95% CI: 1.16 to 1.32) for three prescriptions, 1.30 (95% CI: 1.20 to 1.41) for four prescriptions, and less than a 5% increase for more prescriptions. Early-life antibiotic exposure is associated with the risk of childhood overweight or obesity in a dose-response manner. Further studies are needed to confirm our results.
Keywords: antibiotics; dose-response meta-analysis; obesity; overweight.
© 2021 World Obesity Federation.
References
REFERENCES
-
- Allwell-Brown G, Hussain-Alkhateeb L, Kitutu FE, Strömdahl S, Mårtensson A, Johansson EW. Trends in reported antibiotic use among children under 5 years of age with fever, diarrhoea, or cough with fast or difficult breathing across low-income and middle-income countries in 2005-17: a systematic analysis of 132 national surveys from 73 countries. Lancet Glob Health. 2020;8(6):e799-e807. https://doi.org/10.1016/S2214-109X(20)30079-6
-
- Shekhar S, Petersen FC. The dark side of antibiotics: adverse effects on the infant immune defense against infection. Front Pediatr. 2020;8:544460. Published 2020 Oct 15. https://doi.org/10.3389/fped.2020.544460
-
- Cox LM, Blaser MJ. Antibiotics in early life and obesity. Nat Rev Endocrinol. 2015;11(3):182-190. https://doi.org/10.1038/nrendo.2014.210
-
- Rogawski ET, Platts-Mills JA, Seidman JC, et al. use of antibiotics in children younger than two years in eight countries: a prospective cohort study [published correction appears in Bull World Health Organ. 2017 Feb 1;95(2):164]. Bull World Health Organ. 2017;95(1):49-61. https://doi.org/10.2471/BLT.16.176123
-
- Jackson C, Hsia Y, Bielicki JA, et al. Estimating global trends in total and childhood antibiotic consumption, 2011-2015. BMJ Glob Health. 2019;4(1):e001241 Published 2019 Feb 27. https://doi.org/10.1136/bmjgh-2018-001241
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
